Where L1 sees opportunities ahead, after clawing its way back
Dispelling some common market myths
Watermark Funds Management
Brace yourself for big yields and big potential
5 reasons value stocks could be set to run
Lazard Asset Management
The barbell effect of COVID-19
COVID and tech: what have we learned as investors?
This earnings season question: to virus-adjust earnings or not?
Castle Point Funds
Vaccine or no vaccine: Hamish Douglass is preparing for either scenario
Trial and Error: What SARS-CoV-2 and COVID 19 Exit Planning have in common
Realm Investment House